Trials / Recruiting
RecruitingNCT05396612
Role of the Immune Environment in Response to Therapy in Breast Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.
Conditions
- Breast Cancer
- ER Positive Breast Cancer
- HER2-negative Breast Cancer
- TNBC - Triple-Negative Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver. | Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver. |
Timeline
- Start date
- 2022-10-03
- Primary completion
- 2032-12-31
- Completion
- 2032-12-31
- First posted
- 2022-05-31
- Last updated
- 2025-07-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05396612. Inclusion in this directory is not an endorsement.